TMCnet - World's Largest Communications and Technology Community



Research and Markets: Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems
[April 22, 2014]

Research and Markets: Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" report to their offering.

Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment).

The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market.

Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years.

Synthetic biology market by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market.

Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period.

The global synthetic biology market is segmented into the following categories:


  • Core Products
  • - Synthetic DNA
  • - Synthetic Genes
  • - Synthetic Cells
  • - XNA (Xeno (News - Alert) Nucleic Acid)
  • - Chasis Organisms
  • Enabling Products
  • - DNA Synthesis
  • - Oligonucleotide Synthesis


  • Genome Engineering
  • DNA Sequencing
  • Bioinformatics
  • Biological Components and Integrated Systems


  • Healthcare
  • Chemicals (Including Bio-Fuels)
  • Agriculture
  • Others (Biosecurity, R&D, Energy and Environment)

Key Topics Covered:

  1. Introduction
  2. Executive Summary
  3. Market Overview
  4. Global Synthetic Biology Market, by Products
  5. Global Synthetic Biology Market, by Technologies
  6. Global Synthetic Biology Market, by Applications
  7. Global Synthetic Biology Market, by Geography
  8. Competitive Landscape
  9. Recommendations
  10. Company Profiles
  • Agrivida, Inc.
  • Amyris, Inc.
  • Algenol Biofuels, Inc.
  • ATG (News - Alert):biosynthetics GmbH
  • Bayer AG
  • Bristol-Myers Squibb
  • Biosearch Technologies, Inc.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt (News - Alert) Technologies
  • DuPont, Inc.
  • Evolva SA
  • Exxon Mobil Corporation
  • Ginkgo Bioworks
  • GeneWorks Pty Ltd.
  • Genomatica, Inc.
  • GeneScript Corporation
  • Gevo, Inc.
  • Green Biologics Limited
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • REG Life Sciences, LLC
  • Royal DSM (News - Alert)
  • Thermo Fisher Scientific, Inc.

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy